Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells.
Young KS, Hancock GR, Fink EC, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez MC, Mon KS, Bosland M, Zak DR, Runde AP, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW.
Young KS, et al. Among authors: zak dr.
Breast Cancer Res. 2025 Jan 17;27(1):10. doi: 10.1186/s13058-024-01945-z.
Breast Cancer Res. 2025.
PMID: 39825366